Inhibition of sensory afferents activation and visceral pain by a brominated algal diterpene

Neurogastroenterology and Motility

Volumn 24, Issue 7, 2012, Pages

  Chatter, R ^a,b,c,d   Cenac, N ^b,c,d   Roussis, V ^e   Kharrat, R ^a   Vergnolle, N ^b,c,d  

^a PASTEUR INSTITUTE OF TUNIS   (Tunisia)

^b INSERM   (France)

^c CNRS   (France)

^d UNIVERSITÉ PAUL SABATIER   (France)

^e UNIVERSITY OF ATHENS   (Greece)

Author keywords

Analgesia; Diterpene; Intestine; Opioids; Pain; Primary afferents; Visceral hypersensitivity

Indexed keywords

ACETYLSALICYLIC ACID; AGENTS INTERACTING WITH TRANSMITTER, HORMONE OR DRUG RECEPTORS; ALGAL EXTRACT; ALLYL ISOTHIOCYANATE; ANALGESIC AGENT; CALCIUM ION; CAPSAICIN; DELTA OPIATE RECEPTOR; DITERPENE; HISTAMINE; KAPPA OPIATE RECEPTOR; LAURENCIA GLANDULIFERA EXTRACT; MU OPIATE RECEPTOR; NALOXONE; O 11,15 CYCLO 14 BROMO 14,15 DIHYDROROGIOL 3,11 DIOL; PERTUSSIS TOXIN; POTASSIUM CHLORIDE; PROTEINASE ACTIVATED RECEPTOR 2 AGONIST; UNCLASSIFIED DRUG; VANILLOID RECEPTOR AGONIST; VLC 5;

ABDOMINAL PAIN; ANALGESIC ACTIVITY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CALCIUM CELL LEVEL; CALCIUM MOBILIZATION; CALCIUM SIGNALING; CELL VIABILITY; COLON; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CYTOTOXICITY; DOSE RESPONSE; DRUG INHIBITION; DRUG MECHANISM; LAURENCIA; LAURENCIA GLANDULIFERA; MALE; MOUSE; MUSCLE SPINDLE AFFERENT NERVE; NEUROMODULATION; NONHUMAN; PRIORITY JOURNAL; SPINAL CORD NERVE CELL; SPINAL GANGLION; VISCERAL PAIN;

ANALGESICS; ANIMALS; CALCIUM SIGNALING; COLON; DISEASE MODELS, ANIMAL; DITERPENES; HYPERALGESIA; MALE; MICE; MICE, INBRED C57BL; MUSTARD PLANT; NEURONS, AFFERENT; PHYTOTHERAPY; PLANT OILS; RHODOPHYTA; VISCERAL PAIN;

EID: 84862659468     PISSN: 13501925     EISSN: 13652982     Source Type: Journal    
DOI: 10.1111/j.1365-2982.2012.01940.x     Document Type: Article

References (30)

1. Chatter R, Ben Othman R, Rabhi S et al. In vivo and in vitro anti-inflammatory activity of neorogioltriol, a new diterpene extracted from the red algae Laurencia glandulifera. Mar Drugs 2011; 9: 1293-306.
2. Chatter RKM, Tarhouni S, Maatoug R, Kharrat R, Vagias C, Roussis R. Neorogioltriol: a brominated diterpene with analgesic activity from Laurencia glandulifera. Phytochem Lett 2009; 10: 25-8.
3. Laurent D, Guella G, Roquebert MF, Farinole F, Mancini I, Pietra F. Cytotoxins, mycotoxins and drugs from a new deuteromycete, Acremonium neo-caledoniae, from the southwestern lagoon of New Caledonia. Planta Med 2000; 66: 63-6.
4. Iliopoulou D, Mihopoulos N, Roussis V, Vagias C. New brominated labdane diterpenes from the red alga Laurencia obtusa. J Nat Prod 2003; 66: 1225-8.
5. Iliopoulou D, Mihopoulos N, Vagias C, Papazafiri P, Roussis V. Novel cytotoxic brominated diterpenes from the red alga Laurencia obtusa. J Org Chem 2003; 68: 7667-74.
6. Holzhausen M, Spolidorio LC, Ellen RP et al. Protease-activated receptor-2 activation: a major role in the pathogenesis of Porphyromonas gingivalis infection. Am J Pathol 2006; 168: 1189-99.
7. Laird JM, Martinez-Caro L, Garcia-Nicas E, Cervero F. A new model of visceral pain and referred hyperalgesia in the mouse. Pain 2001; 92: 335-42.
8. Auge C, Balz-Hara D, Steinhoff M, Vergnolle N, Cenac N. Protease-Activated Receptor-4 (PAR4): a role as inhibitor of visceral pain and hypersensitivity. Neurogastroenterol& Motil 2009; 21: 1189-e1107.
9. Nelson L, Vergnolle N, D'Mello C, Chapman K, Le T, Swain MG. Endogenous opioid-mediated antinociception in cholestatic mice is peripherally, not centrally, mediated. J Hepatol 2006; 44: 1141-9.
10. Boue J, Blanpied C, Brousset P, Vergnolle N, Dietrich G. Endogenous opioid-mediated analgesia is dependent on adaptive T cell response in mice. J Immunol 2011; 186: 5078-84.
11. Boue J, Blanpied C, Djata-Cabral M, Pelletier L, Vergnolle N, Dietrich G. Immune conditions associated with CD4(+) T effector-induced opioid release and analgesia. Pain 2012; 153: 485-93.
12. Cenac N, Altier C, Chapman K, Liedtke W, Zamponi G, Vergnolle N. Transient receptor potential vanilloid-4 has a major role in visceral hypersensitivity symptoms. Gastroenterology 2008; 135: 937-46.
13. Cenac N, Altier C, Motta JP et al. Potentiation of TRPV4 signalling by histamine and serotonin: an important mechanism for visceral hypersensitivity. Gut 2010; 59: 481-8.
14. Cenac N, Andrews CN, Holzhausen M et al. Role for protease activity in visceral pain in irritable bowel syndrome. J Clin Invest 2007; 117: 636-47.
15. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 1983; 65: 55-63.
16. D'Aldebert E, Cenac N, Rousset P et al. Transient receptor potential vanilloid 4 activated inflammatory signals by intestinal epithelial cells and colitis in mice. Gastroenterology 2011; 140: 275-85.
17. Vairappan CS, Ishii T, Lee TK, Suzuki M, Zhaoqi Z. Antibacterial activities of a new brominated diterpene from Borneon Laurencia spp. Mar Drugs 2010; 8: 1743-49.
18. Smyrniotopoulos V, Vagias C, Rahman MM, Gibbons S, Roussis V. Structure and antibacterial activity of brominated diterpenes from the red alga Sphaerococcus coronopifolius. Chem Biodivers 2010; 7: 186-95.
19. Smyrniotopoulos V, Vagias C, Bruyere C, Lamoral-Theys D, Kiss R, Roussis V. Structure and in vitro antitumor activity evaluation of brominated diterpenes from the red alga Sphaerococcus coronopifolius. Bioorg Med Chem 2010; 18: 1321-30.
20. Chen LM, Liang YJ, Zhang X et al. Reversal of P-gp-mediated multidrug resistance by Bromotetrandrine in vivo is associated with enhanced accumulation of chemotherapeutical drug in tumor tissue. Anticancer Res 2009; 29: 4597-604.
21. Piros ET, Hales TG, Evans CJ. Functional analysis of cloned opioid receptors in transfected cell lines. Neurochem Res 1996; 21: 1277-85.
22. Gaveriaux-Ruff C, Kieffer BL. Delta opioid receptor analgesia: recent contributions from pharmacology and molecular approaches. Behav Pharmacol 2011; 22: 405-14.
23. Steinhoff M, Vergnolle N, Young SH et al. Agonists of proteinase-activated receptor 2 induce inflammation by a neurogenic mechanism. Nat Med 2000; 6: 151-8.
24. Vergnolle N, Bunnett NW, Sharkey KA et al. Proteinase-activated receptor-2 and hyperalgesia: a novel pain pathway. Nat Med 2001; 7: 821-6.
25. Vergnolle N. Neuroimmune signalling in the gut - mediators linked to disorders? Neurogastroenterol Motil 2006; 18: 497-8.
26. Vergnolle N. Postinflammatory visceral sensitivity and pain mechanisms. Neurogastroenterol Motil 2008; 20(Suppl 1): 73-80.
27. Collins SM, Denou E, Verdu EF, Bercik P. The putative role of the intestinal microbiota in the irritable bowel syndrome. Dig Liver Dis 2009; 41: 850-3.
28. Cremon C, Carini G, De Giorgio R, Stanghellini V, Corinaldesi R, Barbara G. Intestinal dysbiosis in irritable bowel syndrome: etiological factor or epiphenomenon? Expert Rev Mol Diagn 2010; 10: 389-93.
29. Vergnolle N. Protease-activated receptors as drug targets in inflammation and pain. Pharmacol Ther 2009; 123: 292-309.
30. Vergnolle N. Visceral afferents: what role in post-inflammatory pain? Auton Neurosci 2010; 153: 79-83.